Overall, our study confirms the pharmacological activity of the brown strain of F. velutipes for renal protection via the TLR4/NF-κB, MAPK, Nrf2/HO-1, and PI3K/AKT pathways and provides new evidence for its use as a nutritional support for patients with AKI. This evidence concerns the gene AKT1 and acute kidney injury.